2021-02-24

2021-04-15

BIOL. The Adjourned BIOLASE Special Meeting Reconvenes Tuesday, February 16, 2021. FOOTHILL RANCH, Calif., Feb. 1, 2021/PRNewswire/ -- BIOLASE, Inc.(NASDAQ: BIOL), the global leader in dental 2021-02-21 · Then, late last week, the company gained attention following patent news. In particular, this wasn’t found on the company’s headlines but from European Patent Office’s website. Biolase, Inc. received an Intention to Grant a European Patent for Application No. 13155470.1, titled: MODIFIED-OUTPUT FIBER OPTIC TIPS. 2021-04-15 · With its current market valuation of $128.26 Million, BIOLASE, Inc. is set to declare its quarterly results on March 25, 2021.

Biolase is committed to elevating the standard of care in dentistry, allowing clinicians Patent - Device and Method for Stimulation of MagnetohydrodynamicsA -0.06 (-7.79%). Updated Apr 16, 2021 04:00 PM ET Trades from $1. Biolase, Inc. (BIOL) Quote Overview » Zacks Research » Biolase, Inc. (BIOL) Style Scores 20 Jul 2011 The U.S. Patent and Trademark Office has issued Biolase Technology two new patents covering the use of its laser technologies for treating UNİMED VE DENTAL LAZERLER. Biolase, dental sert ve yumuşak doku lazer pazarında 28 yıldan beri teknolojinin öncüsü olarak 50'nin üzerinde patent ile 26 Jan 2018 CAO Group filed patent infringement lawsuits against BIOLASE in the United States District Court for the The lawsuits involve the BIOLASE EPIC, ezlase and iLase diode laser product lines. Wednesday, March 17, 2021& 24 Feb 2021 24, 2021 -- BIOLASE, Inc. , the global leader in dental lasers, and 40 patent- pending technologies designed to provide biologically and BySeeking Alpha- Feb 04, 2021. BIOLASE (NASDAQ:BIOL) regains Nasdaq compliance with the minimum bid price requirement.The company received notice Technical, legal and business information about patents.

Matt Johnson is one of the Firm's primary contacts on practice before the USPTO's Patent Trial and Appeal Board (PTAB), where patentability of issued patents Biolase market cap as of April 14, 2021 is $0.13B. The Company's products incorporate patented and patent pending technologies designed to provide $BIOL search #Biolase on Instagram and then hit “most recent”, look how many people Penny Stocks To Watch For January 2021 => markets.financialcontent.

BIOLASE Raises $14.4M From Maxim Group At 15% Discount. BIOLASE Inc (NASDAQ: BIOL) has announced to sell 14 million common shares at $1.03 per share, raising $14.4 million in gross proceeds.

The fluid may be conditioned by adding flavors, antiseptics and/or tooth whitening agents such as peroxide, medications, and pigments. 2021-04-12 · BIOLASE, Inc. has a market cap of $152.4 Million and is expected to release its quarterly earnings report on March 25, 2021. With its Forward Dividend at 0 and a yield of 0%, the company’s investors could be worried for the BIOL stock to lose ahead of the earnings release.

March 30, 2021 BIOLASE notes the goal of the program is to offer residents hands-on experience with dental lasers that are already in use

A great opportunity to learn from Plastic Aesthetic and Reconstructive Surgeon, Dr Mario Trelles who has extensive, lifetime experience working with almost every kind of laser in aesthetic surgery.

Wednesday, March 17, 2021& 24 Feb 2021 24, 2021 -- BIOLASE, Inc. , the global leader in dental lasers, and 40 patent- pending technologies designed to provide biologically and BySeeking Alpha- Feb 04, 2021.
Japan kapitalism

Patent number: 10877630. Abstract: Embodiments of the invention provide a system of controlling a dental laser system. The system can include a dental laser and a control system for controlling certain functions of the dental laser.

The system can include a dental laser and a control system for controlling certain functions of the dental laser. 2021-03-14 · Biolase is a producer of dental lasers that are used in a large range of procedures. With over 271 patented and 40 patent-pending technologies, Biolase is constantly innovating with its products. The patents it holds for its lasers allow it to claim some of the most advanced dental laser system options on the market.
Opinion leaders

2 days ago

Patent number: 10877630.

2021-01-26

The Company's products incorporate patented and patent pending technologies designed to provide $BIOL search #Biolase on Instagram and then hit “most recent”, look how many people Penny Stocks To Watch For January 2021 => markets.financialcontent. co. 10,877,630 by the US Patent and Trademark Office on 12/29, titled: Denta Trending now. Biolase Inc.0.71 0.06(7.79%). Watch. Biolase Inc.NASDAQ Updated Apr 16, 2021 11:58 PM. BIOL0.71 0.06 (7.79%).

FOOTHILL RANCH, Calif., Jan. 5, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, announced today that Todd Norbe, President and Chief Executive Officer and John Beaver, Chief Operating Officer and Chief Financial Officer, will be providing an overview of the Company, as well as recent progress and achievements, at the H.C. Wainwright BIOCONNECT 2021 Investor Conference, which takes place January 11-14, 2021. 2021-01-12 · By William White, InvestorPlace Writer Jan 12, 2021, 1:53 pm EDT January 12, 2021 Biolase (NASDAQ: BIOL ) stock is flying high on Tuesday after announcing a massive deal for its dental lasers 2021-01-05 · Bloomberg the Company & Its Products The Company & its Products Bloomberg Terminal Demo Request Bloomberg Anywhere Remote Login Bloomberg Anywhere Login Bloomberg Customer Support Customer Support FOOTHILL RANCH, Calif., Feb. 1, 2021 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, encourages stockholders to vote their shares with respect to the adjourned 2 dagar sedan · In last trading session, BIOLASE, Inc. (NASDAQ:BIOL) saw 5,850,207 shares changing hands with its beta currently measuring 1.54. Company’s recent per share price level of $0.77 trading at -$0.08 or -9.41% at ring of the bell on the day assigns it a market valuation of $115.02 Million. That closing 2021-04-12 · BIOLASE Inc. (NASDAQ:BIOL) went down by -0.98% from its latest closing price compared to the recent 1-year high of $1.51. The company’s stock price has collected 21.54% of gains in the last five trading sessions.